Hanmi Pharmaceuticals Co Ltd (128940) – Strategy, SWOT and Corporate Finance Report

Hanmi Pharmaceuticals Co Ltd (128940) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Hanmi Pharmaceuticals Co Ltd (Hanmi Pharmaceuticals), a subsidiary of Hanmi Science Co Ltd, develops prescription drugs and over the counter (OTC) drugs. The company’s prescription drugs include antibiotics, antidiarrheal, osteoporosis, liver supplements and antiemetics. It provides OTC products such as nutritional supplements, calcium supplement, vitamins, among others. Hanmi Pharmaceuticals products are used in the treatment of cancer, depression, dementia, dermatology, diabetes, anti-inflammatory, cardiovascular, epilepsy, hepatitis, hypnotics, osteoarthritis, gastrointestinal, osteoporosis and others. The company operates through its manufacturing facilities located in Hwaseong, Songpa and Pyeongtaek, South Korea. Hanmi Pharmaceuticals is headquartered in Seoul, South Korea.

Scope

• Detailed information on Hanmi Pharmaceuticals Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Hanmi Pharmaceuticals Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Hanmi Pharmaceuticals Co Ltd including a breakdown and examination of key business segments

• News about Hanmi Pharmaceuticals Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Hanmi Pharmaceuticals Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Hanmi Pharmaceuticals Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Hanmi Pharmaceuticals Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

GC Biopharma Corp

Daewoong Pharmaceutical Co Ltd

Dong-A Socio Holdings Co Ltd

JW Holdings Corp

Yuhan Corp

Dong-A Socio Holdings Co Ltd

Yuhan Corp

GC Biopharma Corp

Daewoong Pharmaceutical Co Ltd

JW Holdings Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Hanmi Pharmaceuticals Co Ltd - Key Facts

Hanmi Pharmaceuticals Co Ltd - Key Employees

Hanmi Pharmaceuticals Co Ltd - Key Employee Biographies

Hanmi Pharmaceuticals Co Ltd - Major Products and Services

Hanmi Pharmaceuticals Co Ltd - History

Hanmi Pharmaceuticals Co Ltd - Company Statement

Hanmi Pharmaceuticals Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Hanmi Pharmaceuticals Co Ltd - Business Description

Product Category: Licensing Royalties

Performance

Product Category: Other Sales

Performance

Product Category: Beijing Hanmi

Overview

Performance

Key Stats

Product Category: Hanmi Fine Chem

Overview

Performance

Product Category: Hanmi Pharm

Overview

Performance

R&D Overview

Hanmi Pharmaceuticals Co Ltd - Corporate Strategy

Hanmi Pharmaceuticals Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Hanmi Pharmaceuticals Co Ltd - Strengths

Hanmi Pharmaceuticals Co Ltd - Weaknesses

Hanmi Pharmaceuticals Co Ltd - Opportunities

Hanmi Pharmaceuticals Co Ltd - Threats

Hanmi Pharmaceuticals Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022

Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 22, 2022: Hanmi Fine Chemical launches 'high-tech CDMO' business

Mar 10, 2022: Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors

Oct 27, 2021: Beijing Hanmi Pharmaceuticals opens new fields of pharmaceutical & storage automation-interview with completion of intelligent automated warehouse & pharmaceutical production line in 2021

Jul 29, 2021: Hanmi Pharm achieves strong results in the second quarter through COVID-19

Jul 01, 2021: Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

Feb 12, 2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines

Feb 04, 2021: Hanmi Pharm last year’s sales of KRW

1.75.9 trillion and investment of KRW

226.1 billion in R&D

Jan 29, 2021: JVM achieved good results last year with sales of

115.4 billion won and operating profit of

15.7 billion won

Jan 18, 2021: Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

Jan 12, 2021: Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Hanmi Pharmaceuticals Co Ltd, Key Facts

Hanmi Pharmaceuticals Co Ltd, Key Employees

Hanmi Pharmaceuticals Co Ltd, Key Employee Biographies

Hanmi Pharmaceuticals Co Ltd, Major Products and Services

Hanmi Pharmaceuticals Co Ltd, History

Hanmi Pharmaceuticals Co Ltd, Other Locations

Hanmi Pharmaceuticals Co Ltd, Key Competitors

Hanmi Pharmaceuticals Co Ltd, Ratios based on current share price

Hanmi Pharmaceuticals Co Ltd, Annual Ratios

Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont…1)

Hanmi Pharmaceuticals Co Ltd, Annual Ratios (Cont…2)

Hanmi Pharmaceuticals Co Ltd, Interim Ratios

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022

Hanmi Pharmaceuticals Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Hanmi Pharmaceuticals Co Ltd, Performance Chart (2017 – 2021)

Hanmi Pharmaceuticals Co Ltd, Ratio Charts

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Hanmi Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports